News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
475,400 Results
Type
Article (25564)
Company Profile (159)
Press Release (449670)
Multimedia
Podcasts (51)
Webinars (14)
Section
Business (124600)
Career Advice (466)
Deals (20546)
Drug Delivery (52)
Drug Development (79518)
Employer Resources (44)
FDA (12733)
Job Trends (9394)
News (234489)
Policy (18760)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (1704)
Academic (1)
Accelerated approval (27)
Adcomms (29)
Allergies (131)
Alliances (34142)
ALS (170)
Alzheimer's disease (1633)
Antibody-drug conjugate (ADC) (306)
Approvals (13029)
Artificial intelligence (453)
Autoimmune disease (144)
Automation (27)
Bankruptcy (146)
Best Places to Work (8181)
BIOSECURE Act (12)
Biosimilars (134)
Biotechnology (119)
Bladder cancer (153)
Brain cancer (57)
Breast cancer (626)
Cancer (4646)
Cardiovascular disease (374)
Career advice (417)
Career pathing (19)
CAR-T (271)
CDC (11)
Celiac Disease (2)
Cell therapy (688)
Cervical cancer (36)
Clinical research (69415)
Collaboration (1471)
Company closure (3)
Compensation (846)
Complete response letters (44)
COVID-19 (2163)
CRISPR (74)
C-suite (695)
Cystic fibrosis (136)
Data (6071)
Decentralized trials (2)
Denatured (21)
Depression (134)
Diabetes (420)
Diagnostics (5403)
Digital health (34)
Diversity (11)
Diversity, equity & inclusion (17)
Drug discovery (201)
Drug pricing (50)
Drug shortages (13)
Duchenne muscular dystrophy (198)
Earnings (50314)
Editorial (25)
Employer branding (3)
Employer resources (43)
Events (77496)
Executive appointments (797)
FDA (15552)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (21)
Funding (1253)
Gene editing (170)
Generative AI (41)
Gene therapy (525)
GLP-1 (735)
Government (2361)
Grass and pollen (6)
Guidances (299)
Healthcare (13798)
HIV (45)
Huntington's disease (47)
IgA nephropathy (81)
Immunology and inflammation (218)
Immuno-oncology (48)
Indications (99)
Infectious disease (2369)
Inflammatory bowel disease (189)
Inflation Reduction Act (4)
Influenza (95)
Intellectual property (205)
Interviews (65)
IPO (11023)
IRA (13)
Job creations (1539)
Job search strategy (361)
JPM (30)
Kidney cancer (16)
Labor market (36)
Layoffs (331)
Leadership (16)
Legal (2326)
Liver cancer (83)
Longevity (13)
Lung cancer (626)
Lymphoma (360)
Machine learning (31)
Management (14)
Manufacturing (506)
MASH (156)
Medical device (9567)
Medtech (9609)
Mergers & acquisitions (10394)
Metabolic disorders (1026)
Multiple sclerosis (151)
NASH (14)
Neurodegenerative disease (306)
Neuropsychiatric disorders (80)
Neuroscience (2788)
Neurotech (1)
NextGen: Class of 2026 (3905)
Non-profit (2455)
Now hiring (37)
Obesity (428)
Opinion (182)
Ovarian cancer (159)
Pain (191)
Pancreatic cancer (220)
Parkinson's disease (273)
Partnered (24)
Patents (391)
Patient recruitment (488)
Peanut (52)
People (38832)
Pharmaceutical (36)
Pharmacy benefit managers (7)
Phase 1 (22356)
Phase 2 (30897)
Phase 3 (22404)
Pipeline (4699)
Policy (103)
Postmarket research (2056)
Preclinical (8063)
Press Release (28)
Prostate cancer (226)
Psychedelics (40)
Radiopharmaceuticals (272)
Rare diseases (749)
Real estate (2964)
Recruiting (17)
Regulatory (17804)
Reports (26)
Research institute (1891)
Resumes & cover letters (67)
Rett syndrome (27)
RNA editing (14)
RSV (48)
Schizophrenia (134)
Series A (223)
Series B (179)
Service/supplier (8)
Sickle cell disease (81)
Special edition (15)
Spinal muscular atrophy (151)
Sponsored (27)
Startups (2435)
State (1)
Stomach cancer (15)
Supply chain (52)
Tariffs (22)
The Weekly (30)
Vaccines (705)
Venture capital (55)
Weight loss (242)
Women's health (74)
Worklife (6)
Date
Today (33)
Last 7 days (492)
Last 30 days (1657)
Last 365 days (25523)
2026 (2417)
2025 (25791)
2024 (29365)
2023 (33189)
2022 (41109)
2021 (43073)
2020 (39630)
2019 (30655)
2018 (23080)
2017 (23895)
2016 (21814)
2015 (25515)
2014 (18419)
2013 (13854)
2012 (14520)
2011 (14864)
2010 (14006)
Location
Africa (379)
Alabama (73)
Alaska (3)
Arizona (172)
Arkansas (8)
Asia (29115)
Australia (5654)
California (9775)
Canada (2510)
China (1014)
Colorado (391)
Connecticut (400)
Delaware (276)
Europe (66500)
Florida (1349)
Georgia (305)
Hawaii (2)
Idaho (41)
Illinois (577)
India (41)
Indiana (402)
Iowa (17)
Japan (376)
Kansas (98)
Kentucky (33)
Louisiana (19)
Maine (27)
Maryland (1048)
Massachusetts (6951)
Michigan (198)
Minnesota (410)
Mississippi (4)
Missouri (92)
Montana (30)
Nebraska (17)
Nevada (102)
New Hampshire (67)
New Jersey (2459)
New Mexico (23)
New York (2566)
North Carolina (1206)
North Dakota (6)
Northern California (4807)
Ohio (253)
Oklahoma (20)
Oregon (36)
Pennsylvania (1887)
Puerto Rico (14)
Rhode Island (24)
South America (494)
South Carolina (43)
Southern California (3856)
Tennessee (132)
Texas (1572)
United States (33319)
Utah (262)
Vermont (1)
Virginia (214)
Washington D.C. (54)
Washington State (777)
West Virginia (2)
Wisconsin (80)
Wyoming (1)
475,400 Results for "clinical ink".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bioprinting and Bio-inks: Shifting Paradigms in Regenerative Medicine and Future Economic Outlook, Commentary by unexakorea
January 2, 2026
·
1 min read
Press Releases
Guided Therapeutics Inks Initial $200,000 Deal with New Distribution Partner Yuanshuo Medical Instruments Corporation
November 20, 2025
·
2 min read
Antibody-drug conjugate (ADC)
Roche Inks Another China ADC Pact With $1.5B Hansoh Bet
Roche will gain worldwide rights outside of the Greater China region to Hansoh’s HS-20110, an antibody-drug conjugate in early-stage development for colorectal cancer.
October 17, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Sanofi Inks $9.5B Blueprint Buyout to Expand Rare Disease Portfolio
Blueprint has a next-generation systemic mastocytosis treatment, called elenestinib, that Sanofi CEO Paul Hudson told analysts provides an “opportunity to grow through the ‘30s.”
June 2, 2025
·
3 min read
·
Nick Paul Taylor
Collaboration
Boehringer Ingelheim Bets up to Nearly $1B in ADC Play With AimedBio Deal
2025 has been a busy year for Boehringer Ingelheim, which has so far inked at least five hefty partnerships—including its latest one with South Korea’s AimedBio for an antibody-drug conjugate therapy for cancer.
October 15, 2025
·
2 min read
·
Tristan Manalac
Obesity
Lilly Inks Deal Worth up to $870M To Develop Long-Acting GLP-1 Obesity Drugs
Eli Lilly joins up with Camurus to make long-acting versions of the pharma’s obesity and diabetes drugs, joining the industry’s growing pipeline of programs that are differentiated by the frequency of dosing.
June 4, 2025
·
2 min read
·
Nick Paul Taylor
FDA
FDA Policy Tracker: 2025 Was a Year of Change
Policy initiatives have come fast and furious at the FDA this year. While guidances on rare diseases and vaccines have consumed most of the ink, policy shifts aimed at improving FDA efficiencies and reshoring U.S. manufacturing also got some attention. Here,
BioSpace
rounds up more than a dozen initiatives relevant to the biopharma industry.
December 22, 2025
·
13 min read
·
Heather McKenzie
Obesity
Obesity Late-Comer AbbVie Inks up to $2.2B Amylin Deal With Gubra
AbbVie is joining the amylin arena, though the pharma is still far behind leaders Novo Nordisk and Eli Lilly.
March 3, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Siren Biotechnology to Showcase Clinical-Stage Momentum at Major 2026 Healthcare Conferences
January 8, 2026
·
2 min read
Bio NC
Nature Publishes Work Demonstrating Clinical ink Technology Sensitivity to Parkinson’s Disease
Clinical ink, a global life science technology company, announces the publication of “Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study” in npj Parkinson’s Disease.
May 15, 2023
·
1 min read
1 of 47,540
Next